MICROPROPAGAÇÃO DE CLONES DE BANANA cv. TERRA EM BIORREATOR DE IMERSÃO TEMPORÁRIA MICROPROPAGATION OF BANANA TERRA USING TEMPORARY IMMERSION BIOREACTORS

Mudas micropropagadas de banana têm sido ofertadas ao mercado com o intuito de suprir a demanda de uma fruticultura cada vez mais tecnificada. Os preços mais elevados deste tipo de muda têm sido um dos maiores entraves ao seu uso. Vários são os fatores que oneram o seu preço final: mão-de-obra especializada, necessidade de laboratórios bem equipados, estrutura de aclimatização apropriada, baixa taxa de multiplicação de algumas variedades, etc. O presente trabalho relata a micropropagação de bananeiras cv. Terra, utilizando biorreatores de imersão temporária, com o objetivo de aumentar a taxa de multiplicação e diminuir os custos de produção das mudas. Os resultados obtidos mostraram que o ciclo de imersão de 4 horas e a renovação do meio de cultura aos 30 dias foram essenciais para uma maior produção de biomassa e crescimento dos explantes. A composição do meio de cultura influenciou o desenvolvimento dos explantes de banana cultivados nos biorreatores. Explantes cultivados em meio MS + 3mg/L de BAP com renovação para MS básico, após 30 dias, apresentaram maior produção de biomassa e alta taxa de multiplicação. Comparando-se o biorreator de imersão temporária com o sistema tradicional em semi-sólido, observou-se que, no primeiro, as microplantas apresentaram maior comprimento, produção de biomassa de 2,86 vezes maior e 2,20 vezes mais brotos do que no sistema tradicional.<br>Banana seedlings has been micropropagated and sold to the producers to supply a rather competitive fruit crop market. This high quality propagule has usually a higher price in the market than field propagated seedlings. Several factors contribute to its final costs: need of specialized labour, need of well equipped laboratory and acclimatization structure, low multiplication rate of some varieties etc. The work presented here reports the development of a new way to micropropagate banana var. Terra, a known slow seedling producing variety, by using a temporary immersion bioreactor. The aim of this work was to increase the multiplication rate of this variety of banana and to reduce the costs of production of the micropropagated seedlings. The results showed that the immersion cycle of 4 hours with medium culture renewed at 30 days was essential to a higher biomass and explants growth. The composition of the medium culture positively influenced the development of the banana explants cultured in the bioreactors. Cultured explants in MS medium + 3 mg/L of BAP changed to a basic MS medium after 30 days presented the higher biomass and multiplication rate of all treatments. Traditional cultivation using semi-solid media was compared to a temporary immersion system and the results showed that the temporary immersion system presented 2.86 times more biomass production and 2,20 times more viable shoots than the traditional semi-solid system

Physicians&apos; guideline adherence is associated with long-term heart failure mortality in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry

Background: Physicians&apos; adherence to guideline-recommended therapy is associated with short-term clinical outcomes in heart failure (HF) with reduced ejection fraction (HFrEF). However, its impact on longer-term outcomes is poorly documented. Here, we present results from the 18-month follow-up of the QUALIFY registry. Methods and results: Data at 18 months were available for 6118 ambulatory HFrEF patients from this international prospective observational survey. Adherence was measured as a continuous variable, ranging from 0 to 1, and was assessed for five classes of recommended HF medications and dosages. Most deaths were cardiovascular (CV) (228/394) and HF-related (191/394) and the same was true for unplanned hospitalizations (1175 CV and 861 HF-related hospitalizations, out of a total of 1541). According to univariable analysis, CV and HF deaths were significantly associated with physician adherence to guidelines. In multivariable analysis, HF death was associated with adherence level [subdistribution hazard ratio (SHR) 0.93, 95% confidence interval (CI) 0.87–0.99 per 0.1 unit adherence level increase; P = 0.034] as was composite of HF hospitalization or CV death (SHR 0.97, 95% CI 0.94–0.99 per 0.1 unit adherence level increase; P = 0.043), whereas unplanned all-cause, CV or HF hospitalizations were not (all-cause: SHR 0.99, 95% CI 0.9–1.02; CV: SHR 0.98, 95% CI 0.96–1.01; and HF: SHR 0.99, 95% CI 0.96–1.02 per 0.1 unit change in adherence score; P = 0.52, P = 0.2, and P = 0.4, respectively). Conclusion: These results suggest that physicians&apos; adherence to guideline-recommended HF therapies is associated with improved outcomes in HFrEF. Practical strategies should be established to improve physicians&apos; adherence to guidelines. © 2019 The Authors. European Journal of Heart Failure © 2019 European Society of Cardiolog